The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Angiogenesis Assay Market Research Report 2025
Synopsis
Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.
The global Angiogenesis Assay market was valued at US$ 18 million in 2023 and is anticipated to reach US$ 31 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
Global Angiogenesis Assay key players include Abcam, Bio-Techne, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA, etc. Global top five manufacturers hold a share over 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia Pacific, both have a share nearly 60 percent. In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%. And in terms of application, the largest application is Academic Institution, followed by Biotech Companies, etc.
This report aims to provide a comprehensive presentation of the global market for Angiogenesis Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiogenesis Assay.
Report Scope
The Angiogenesis Assay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiogenesis Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiogenesis Assay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Bio-Techne
Thermo Fisher Scientific
Cell Biolabs, Inc.
BioVision, Inc
PromoCell GmbH
Merck KGaA
Kollodis BioSciences
Sartorius (Essen BioScience)
Creative Bioarray
Segment by Type
In Vitro Assay Kit
In Vivo Assay Kit
Segment by Application
Academic Institution
Biotech Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Angiogenesis Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.
The global Angiogenesis Assay market was valued at US$ 18 million in 2023 and is anticipated to reach US$ 31 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
Global Angiogenesis Assay key players include Abcam, Bio-Techne, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA, etc. Global top five manufacturers hold a share over 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia Pacific, both have a share nearly 60 percent. In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%. And in terms of application, the largest application is Academic Institution, followed by Biotech Companies, etc.
This report aims to provide a comprehensive presentation of the global market for Angiogenesis Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiogenesis Assay.
Report Scope
The Angiogenesis Assay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiogenesis Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiogenesis Assay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Bio-Techne
Thermo Fisher Scientific
Cell Biolabs, Inc.
BioVision, Inc
PromoCell GmbH
Merck KGaA
Kollodis BioSciences
Sartorius (Essen BioScience)
Creative Bioarray
Segment by Type
In Vitro Assay Kit
In Vivo Assay Kit
Segment by Application
Academic Institution
Biotech Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Angiogenesis Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angiogenesis Assay Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 In Vitro Assay Kit
1.2.3 In Vivo Assay Kit
1.3 Market by Application
1.3.1 Global Angiogenesis Assay Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academic Institution
1.3.3 Biotech Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angiogenesis Assay Market Perspective (2019-2030)
2.2 Angiogenesis Assay Growth Trends by Region
2.2.1 Global Angiogenesis Assay Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Angiogenesis Assay Historic Market Size by Region (2019-2024)
2.2.3 Angiogenesis Assay Forecasted Market Size by Region (2025-2030)
2.3 Angiogenesis Assay Market Dynamics
2.3.1 Angiogenesis Assay Industry Trends
2.3.2 Angiogenesis Assay Market Drivers
2.3.3 Angiogenesis Assay Market Challenges
2.3.4 Angiogenesis Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Angiogenesis Assay Players by Revenue
3.1.1 Global Top Angiogenesis Assay Players by Revenue (2019-2024)
3.1.2 Global Angiogenesis Assay Revenue Market Share by Players (2019-2024)
3.2 Global Angiogenesis Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Angiogenesis Assay Revenue
3.4 Global Angiogenesis Assay Market Concentration Ratio
3.4.1 Global Angiogenesis Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angiogenesis Assay Revenue in 2023
3.5 Angiogenesis Assay Key Players Head office and Area Served
3.6 Key Players Angiogenesis Assay Product Solution and Service
3.7 Date of Enter into Angiogenesis Assay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Angiogenesis Assay Breakdown Data by Type
4.1 Global Angiogenesis Assay Historic Market Size by Type (2019-2024)
4.2 Global Angiogenesis Assay Forecasted Market Size by Type (2025-2030)
5 Angiogenesis Assay Breakdown Data by Application
5.1 Global Angiogenesis Assay Historic Market Size by Application (2019-2024)
5.2 Global Angiogenesis Assay Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Angiogenesis Assay Market Size (2019-2030)
6.2 North America Angiogenesis Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Angiogenesis Assay Market Size by Country (2019-2024)
6.4 North America Angiogenesis Assay Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Angiogenesis Assay Market Size (2019-2030)
7.2 Europe Angiogenesis Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Angiogenesis Assay Market Size by Country (2019-2024)
7.4 Europe Angiogenesis Assay Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Angiogenesis Assay Market Size (2019-2030)
8.2 Asia-Pacific Angiogenesis Assay Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Angiogenesis Assay Market Size by Region (2019-2024)
8.4 Asia-Pacific Angiogenesis Assay Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Angiogenesis Assay Market Size (2019-2030)
9.2 Latin America Angiogenesis Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Angiogenesis Assay Market Size by Country (2019-2024)
9.4 Latin America Angiogenesis Assay Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Angiogenesis Assay Market Size (2019-2030)
10.2 Middle East & Africa Angiogenesis Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Angiogenesis Assay Market Size by Country (2019-2024)
10.4 Middle East & Africa Angiogenesis Assay Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Detail
11.1.2 Abcam Business Overview
11.1.3 Abcam Angiogenesis Assay Introduction
11.1.4 Abcam Revenue in Angiogenesis Assay Business (2019-2024)
11.1.5 Abcam Recent Development
11.2 Bio-Techne
11.2.1 Bio-Techne Company Detail
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Angiogenesis Assay Introduction
11.2.4 Bio-Techne Revenue in Angiogenesis Assay Business (2019-2024)
11.2.5 Bio-Techne Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Angiogenesis Assay Introduction
11.3.4 Thermo Fisher Scientific Revenue in Angiogenesis Assay Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Cell Biolabs, Inc.
11.4.1 Cell Biolabs, Inc. Company Detail
11.4.2 Cell Biolabs, Inc. Business Overview
11.4.3 Cell Biolabs, Inc. Angiogenesis Assay Introduction
11.4.4 Cell Biolabs, Inc. Revenue in Angiogenesis Assay Business (2019-2024)
11.4.5 Cell Biolabs, Inc. Recent Development
11.5 BioVision, Inc
11.5.1 BioVision, Inc Company Detail
11.5.2 BioVision, Inc Business Overview
11.5.3 BioVision, Inc Angiogenesis Assay Introduction
11.5.4 BioVision, Inc Revenue in Angiogenesis Assay Business (2019-2024)
11.5.5 BioVision, Inc Recent Development
11.6 PromoCell GmbH
11.6.1 PromoCell GmbH Company Detail
11.6.2 PromoCell GmbH Business Overview
11.6.3 PromoCell GmbH Angiogenesis Assay Introduction
11.6.4 PromoCell GmbH Revenue in Angiogenesis Assay Business (2019-2024)
11.6.5 PromoCell GmbH Recent Development
11.7 Merck KGaA
11.7.1 Merck KGaA Company Detail
11.7.2 Merck KGaA Business Overview
11.7.3 Merck KGaA Angiogenesis Assay Introduction
11.7.4 Merck KGaA Revenue in Angiogenesis Assay Business (2019-2024)
11.7.5 Merck KGaA Recent Development
11.8 Kollodis BioSciences
11.8.1 Kollodis BioSciences Company Detail
11.8.2 Kollodis BioSciences Business Overview
11.8.3 Kollodis BioSciences Angiogenesis Assay Introduction
11.8.4 Kollodis BioSciences Revenue in Angiogenesis Assay Business (2019-2024)
11.8.5 Kollodis BioSciences Recent Development
11.9 Sartorius (Essen BioScience)
11.9.1 Sartorius (Essen BioScience) Company Detail
11.9.2 Sartorius (Essen BioScience) Business Overview
11.9.3 Sartorius (Essen BioScience) Angiogenesis Assay Introduction
11.9.4 Sartorius (Essen BioScience) Revenue in Angiogenesis Assay Business (2019-2024)
11.9.5 Sartorius (Essen BioScience) Recent Development
11.10 Creative Bioarray
11.10.1 Creative Bioarray Company Detail
11.10.2 Creative Bioarray Business Overview
11.10.3 Creative Bioarray Angiogenesis Assay Introduction
11.10.4 Creative Bioarray Revenue in Angiogenesis Assay Business (2019-2024)
11.10.5 Creative Bioarray Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
